HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hypercalcemia and osteoclast activating factor (OAF) associated with acute lymphoblastic leukemia (author's transl)].

Abstract
The occurence of hypercalcemia appears to be unusual in leukemia. The mechanisms are numerous: secretion of PTH of PTH like substance, prostaglandin E2 or vitamin D like sterols. The reported case is one of lymphoblastic acute leukemia and hypercalcemia associated with osteoclast activating factor secreted by leukemic cells. In this patient the serum levels calcium closely paralleled the course of acute leukemia.
AuthorsA Durocher, J J Ballet, J Pirot, F Granier, F Bauters, F Wattel
JournalLa semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris (Sem Hop) 1979 May 18-25 Vol. 55 Issue 19-20 Pg. 1008-10 France
Vernacular TitleHypercalcémie et facteur d'activation des ostéoclastes au cours d'une leucémie aiguë lymphoblastique.
PMID227085 (Publication Type: Case Reports, Journal Article)
Topics
  • Aged
  • Animals
  • Biological Assay
  • Female
  • Humans
  • Hypercalcemia (blood, etiology)
  • Leukemia, Lymphoid (blood, complications)
  • Lymphocytes (metabolism)
  • Mice
  • Osteoclasts

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: